Celcuity
Director, Medical Science Liaison, Carolinas
Celcuity, Minneapolis, Minnesota, United States, 55400
Director, Medical Science Liaison, Carolinas
Title: Director, Medical Science Liaison
Location: Carolinas (North Carolina, South Carolina, Virginia, West Virginia, Tennessee, and Kentucky)
Position Summary We are seeking a Director, MSL who will report to the Senior Director, Eastern US Field Medical. The Director, MSL will be responsible for scientific exchange with Health Care Providers (HCPs) and key decision makers (managed care, payers, formulary committees, etc.) on Celcuity’s products, relevant disease states, and in support of clinical trials. MSL’s combine a strong business acumen, disease state knowledge, clinical knowledge/experience, market awareness, and serve as a conduit for Celcuity’s scientific data to external customers while providing external market and clinical insights internally to cross‑functional teams. Travel within the territory and the US for medical conferences will be expected.
Responsibilities
Identify and cultivate professional relationships KOLs in designated tumor types.
Maintain cross‑functional field partnerships allowing for appropriate collaboration with field commercial teams (sales, market access, etc.), and Clinical Development associates.
Maintain and develop synergistic relationships with KOLs to expand research, advisory, and educational partnership opportunities.
Assist the Clinical Development Team in the identification and education of potential clinical trial sites, assist, upon request, in troubleshooting issues during clinical trial conduct.
Develop scientific expertise on all Celcuity’s products, related disease states, and the clinical practice for a given therapeutic area.
Communicate scientific content, written and verbal, related to Celcuity’s products and related disease states.
Be knowledgeable of and follow all applicable laws, SOPs and guidance documents ensuring compliance.
Provide scientific training to internal colleagues.
Participate in the Medical, Legal, and Regulatory review process, as needed, in the role of scientific expert.
Identify, categorize, and communicate key clinical insights related to assigned disease state and products.
Other duties as assigned.
Qualifications
MD, PharmD, or PhD in Life Sciences, D.Sc., D.N.P, or D.O. degree
Solid tumor oncology experience
Excellent presentation and communication skills
Conveying complex scientific concepts and information appropriately tailored to the audience (internal staff, physicians, nurses, patient advocacy groups, formulary committees, etc.)
3+ years of related pharmaceutical Medical Science Liaison experience
Breast Cancer experience
Knowledge of clinical research design and GCP in the oncology area
Experience at small/start‑up biopharmaceutical company
Strong business acumen
Experience with payor groups, market access teams, formulary committees, and treatment guidelines
Experience managing territory resources and budgets. Demonstrated self‑starter.
Experience launching products
About Us Celcuity is a clinical‑stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth. Our lead therapeutic candidate, gedatolisib, is an intravenously administered, potential first‑in‑class PI3K/AKT/mTOR (PAM) pathway inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings. A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration‑resistant prostate cancer is on‑going.
Compensation & Benefits For this role, the anticipated base pay range is $230,000 -$275,000 DOE. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience. The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package. Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.
Equal‑Opportunity Employer Celcuity is an Equal‑Opportunity Employer and is committed to fair and equitable compensation practices. Celcuity will not be responsible for fees related to recruitment agencies. Celcuity’s receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Celcuity and such organization.
#J-18808-Ljbffr
Location: Carolinas (North Carolina, South Carolina, Virginia, West Virginia, Tennessee, and Kentucky)
Position Summary We are seeking a Director, MSL who will report to the Senior Director, Eastern US Field Medical. The Director, MSL will be responsible for scientific exchange with Health Care Providers (HCPs) and key decision makers (managed care, payers, formulary committees, etc.) on Celcuity’s products, relevant disease states, and in support of clinical trials. MSL’s combine a strong business acumen, disease state knowledge, clinical knowledge/experience, market awareness, and serve as a conduit for Celcuity’s scientific data to external customers while providing external market and clinical insights internally to cross‑functional teams. Travel within the territory and the US for medical conferences will be expected.
Responsibilities
Identify and cultivate professional relationships KOLs in designated tumor types.
Maintain cross‑functional field partnerships allowing for appropriate collaboration with field commercial teams (sales, market access, etc.), and Clinical Development associates.
Maintain and develop synergistic relationships with KOLs to expand research, advisory, and educational partnership opportunities.
Assist the Clinical Development Team in the identification and education of potential clinical trial sites, assist, upon request, in troubleshooting issues during clinical trial conduct.
Develop scientific expertise on all Celcuity’s products, related disease states, and the clinical practice for a given therapeutic area.
Communicate scientific content, written and verbal, related to Celcuity’s products and related disease states.
Be knowledgeable of and follow all applicable laws, SOPs and guidance documents ensuring compliance.
Provide scientific training to internal colleagues.
Participate in the Medical, Legal, and Regulatory review process, as needed, in the role of scientific expert.
Identify, categorize, and communicate key clinical insights related to assigned disease state and products.
Other duties as assigned.
Qualifications
MD, PharmD, or PhD in Life Sciences, D.Sc., D.N.P, or D.O. degree
Solid tumor oncology experience
Excellent presentation and communication skills
Conveying complex scientific concepts and information appropriately tailored to the audience (internal staff, physicians, nurses, patient advocacy groups, formulary committees, etc.)
3+ years of related pharmaceutical Medical Science Liaison experience
Breast Cancer experience
Knowledge of clinical research design and GCP in the oncology area
Experience at small/start‑up biopharmaceutical company
Strong business acumen
Experience with payor groups, market access teams, formulary committees, and treatment guidelines
Experience managing territory resources and budgets. Demonstrated self‑starter.
Experience launching products
About Us Celcuity is a clinical‑stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth. Our lead therapeutic candidate, gedatolisib, is an intravenously administered, potential first‑in‑class PI3K/AKT/mTOR (PAM) pathway inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings. A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration‑resistant prostate cancer is on‑going.
Compensation & Benefits For this role, the anticipated base pay range is $230,000 -$275,000 DOE. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience. The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package. Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.
Equal‑Opportunity Employer Celcuity is an Equal‑Opportunity Employer and is committed to fair and equitable compensation practices. Celcuity will not be responsible for fees related to recruitment agencies. Celcuity’s receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Celcuity and such organization.
#J-18808-Ljbffr